PetVivo Holdings, Inc.·Healthcare

PetVivo Holdings, Inc. (NASDAQ: PETV - Get Free Report) traded up 2.5% during trading on Friday. The company traded as high as $0.7990 and last traded at $0.7990. 3,659 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 11,959 shares. The stock had previously closed at $0.7793. PetVivo

Minneapolis, Minnesota--(Newsfile Corp. - April 21, 2026) - PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, announced today that it will be participating in the Market Movers Investor Summit on Tuesday May 5, 2026. The presentation will take place at 9:40 AM ET at the historic Bank of New York.

PetVivo Holdings, Inc. (NASDAQ: PETV - Get Free Report)'s share price dropped 11% during trading on Tuesday. The stock traded as low as $0.6873 and last traded at $0.7050. Approximately 16,865 shares were traded during trading, an increase of 19% from the average daily volume of 14,208 shares. The stock had previously closed at $0.7920.
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Healthcare
Medical - Devices
20
2014-09-08
1.28